- Immunohistochemical Expression of CXC Chemokine Receptor 4 and Galectin-3 in Follicular Tumors of Thyroid
-
Park JE, Kim BK, Gwoo S, Park YH, Choi YS, Kim YO
- KMID: 2198435
- J Korean Thyroid Assoc.
- 2012 May;5(1):45-51.
- doi: 10.11106/jkta.2012.5.1.45
BACKGROUND AND OBJECTIVES: Follicular tumors can present a difficult diagnostic challenge for cytological evaluation and ultrasound findings. Therefore, new methods which could help distinguish follicular adenoma from follicular carcinoma simply... -
- CITED
-
- Close
- SHARE
-
- Close
- Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer
-
Kim DI, Kim E, Kim YA, Cho SW, Lim JA, Park YJ
- KMID: 2352988
- Endocrinol Metab.
- 2016 Sep;31(3):469-475.
- doi: 10.3803/EnM.2016.31.3.469
BACKGROUND: Tumor associated macrophages (TAMs) and CXC chemokine receptor 4 (CXCR4) have emerged as potential biomarkers in various human cancers. The aims of this study were to investigate the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy
-
Shim B, Jin MS, Moon JH, Park IA, Ryu HS
- KMID: 2427519
- J Pathol Transl Med.
- 2018 Nov;52(6):369-377.
- doi: 10.4132/jptm.2018.09.19
BACKGROUND: Chemokine receptor CXC chemokine receptor type 4 (CXCR4) and its ligand CXC motif chemokine 12 (CXCL12; stromal cell-derived factor-1) are implicated in tumor growth, metastasis, and tumor cell-microenvironment interaction.... -
- CITED
-
- Close
- SHARE
-
- Close
